Hosted on MSN23d
Merck & Co., Inc. (MRK): Among the Most Promising Cancer Stocks According to Hedge Funds
Premier products in Merck’s portfolio include Keytruda, Gardasil, Winrevair and Bravecto. Outsized contributor Keytruda is an ...
Why Merck & Co. (MRK) Is the Best Beginner Stock to Invest in Now?
We recently published a list of 11 Best Beginner Stocks To Invest In Now. In this article, we are going to take a look at ...
Insider Monkey29d
Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio
Premier products in Merck’s portfolio include Keytruda, Gardasil, Winrevair and Bravecto. Outsized contributor Keytruda is an immuno-oncology drug that treats several cancers and tumors.
STAT1mon
Merck licenses Chinese cancer drug, searching for next Keytruda blockbuster
In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from LaNova Medicines, a Shanghai-based firm, for $588 million upfront and ...
Insider Monkey24d
Merck & Co., Inc. (MRK): Among the Most Promising Cancer Stocks According to Hedge Funds
Premier products in Merck’s portfolio include Keytruda, Gardasil, Winrevair and Bravecto. Outsized contributor Keytruda is an immuno-oncology drug that treats several cancers and tumors.